Your session is about to expire
← Back to Search
Video Instruction for Medication Adherence
N/A
Waitlist Available
Research Sponsored by Tufts Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-18 months
Awards & highlights
Study Summary
This trial will test whether a video teaching how to self-administer a common birth control shot is effective and acceptable to patients.
Who is the study for?
This trial is for young individuals assigned female at birth, aged 19 or younger, who have had at least one injection of depot medroxyprogesterone. They must not be wards of the state or prisoners and should have a guardian to consent if under 18. They can't join if they've self-injected before, never had this medication, are pregnant, don't understand English, can't watch the video or have cognitive issues.Check my eligibility
What is being tested?
The study tests whether an instructional video with a peer demonstrating how to self-administer subcutaneous depot medroxyprogesterone is effective and acceptable for adolescents as an alternative to getting shots in a medical office.See study design
What are the potential side effects?
Since participants are already on depot medroxyprogesterone treatment and the intervention is watching a video rather than taking new medication, no additional side effects from medications are being introduced in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Supervised self-injection
Secondary outcome measures
Sustained self-injection
Trial Design
1Treatment groups
Experimental Treatment
Group I: Teaching videoExperimental Treatment1 Intervention
This is a single arm interventional study wherein the subjects enrolled will all participate in the study in the same way by watching the teaching video and then will be asked to self inject subcutaneous depot-medroxyprogesterone as per the protocol. All participants will then be asked to answer survey questions. All health care providers that participate in the study will likewise be asked to answer survey questions.
Find a Location
Who is running the clinical trial?
Tufts Medical CenterLead Sponsor
253 Previous Clinical Trials
253,368 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 and do not have a parent or guardian to sign consent.I am a female under 20 years old.I have experience giving myself injections.I have received at least one depot medroxyprogesterone injection.I have never taken depot medroxyprogesterone.I have difficulty with memory or thinking clearly.
Research Study Groups:
This trial has the following groups:- Group 1: Teaching video
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies available for participants in this research project?
"The clinical trial's entry on clinicaltrials.gov shows that patient recruitment is no longer active for this study, which was first posted on September 29th 2021 and had its last update in September 13th 2022. However, 67 other trials are actively enrolling patients at present time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger